HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Germany’s OTC Market in 2018: Online Sees Double-Digit Growth, Bionorica’s Canephron Uno Tops New Launches

Executive Summary

Germany's online channel continued to expand to expand in 2018, with OTC product sales via mail-order pharmacy growing almost 10-times faster than through bricks-and-mortar pharmacy. Meanwhile, GSK's Voltaren brand was top-seller through both channels and Bionorica's Canephron Uno was the best-selling launch during the 12 months. 

You may also be interested in...



Zantac Recall And EU Regulatory Issues Hurt Sanofi In Q3

Recalling Zantac in North America over contamination concerns and tightening regulatory requirements in Europe combined to impede growth at Sanofi Consumer Healthcare in Q3. New CEO Paul Hudson says he is still taking time to get to know the business before making any strategic moves.

EU Deal Tracker: Polpharma And JGL Join Forces, PharmaNutra Expands Reach, Bionorica Divests Cannabis Unit

Polphama and JGL have struck a deal to distribute one another's ophthalmology products, PharmaNutra has secured expanded distribution for its Cetilar joint pain product, and Bionorica has offloaded its cannabis business to Canada's Canopy.

What’s On German TV This Month? New Ads From Ursapharm, Protina, Medice And Sanofi

New German television advertisements for OTC medicines and dietary supplements from Ursapharm for Hylo Care, Protina for Basica Direkt, Medice for Dorithricin and Sanofi for Thomapyrin Tension Duo.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS148510

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel